Agilent Completes Acquisition of Biocare Medical
Agilent Technologies has completed its acquisition of BroadOak portfolio company Biocare Medical, a global leader in clinical and research pathology solutions. Read…
Read More
InSphero AG Acquires PhenoVista Biosciences, Inc. to Expand Advanced 3D, Cell-based Assay Capabilities
InSphero AG has acquired PhenoVista Biosciences — a merger of two BroadOak portfolio companies combining InSphero's advanced 3D in-vitro models with PhenoVista's…
Read More
Quartzy Announces $23 Million Financing from Avenue Capital Group and BroadOak Capital Partners
HAYWARD, Calif.–(BUSINESS WIRE)–Quartzy, a vertically-integrated procurement platform for the life sciences industry, announced it has secured $23 million in financing from Avenue…
Read More
Harvard Bioscience Announces Successful Completion of Debt Refinancing
BroadOak Capital Partners is proud to support Harvard Bioscience through a comprehensive $40 million growth financing package that strengthens the company's balance…
Read More
BroadOak Capital Partners Adds More Than $200 Million of Permanent Capital to Supplement Investment Platform
*Evergreen capital base enables BroadOak to pursue its life sciences growth capital strategy over a longer horizon of investment cycles and to…
Read More
Codis Raises Growth Capital to Expand Commercial Manufacturing; Welcomes 1315 Capital
BroadOak Capital Partners is proud to support Codis, building on the company's scale, quality, and global reach. The full press release is…
Read More
Codis Launches as Global CDMO for Commercial Spray Drying and Amorphous Solid Dispersions
BroadOak Capital Partners is an investor in Codis – formerly Particle Dynamics. The full press release is below. ST. LOUIS, Oct. 14,…
Read More
Battery Ventures Completes Take-Private Transaction with Enzo Biochem
BroadOak Capital Partners advised the Board of Directors of Enzo Biochem on strategic alternatives and the take-private transaction by Battery Ventures. BOSTON–Battery…
Read More
Scientific Industries completes the divestiture of its Genie division to Troemner, a subsidiary of Mettler-Toledo
BroadOak Capital Partners advised Scientific Industries on the divestiture of its Genie division. The full press release is below. BOHEMIA, N.Y., Aug.…
Read More
Pluristyx Completes Investment Round to Expand Product Portfolio and Commercial Operations
We're pleased to share that Pluristyx, a BroadOak Capital Partners portfolio company, has recently completed an investment round to expand inventory with…
Read More
Particle Dynamics acquires EuroAPI UK
We're pleased to share that Particle Dynamics, a BroadOak Capital Partners portfolio company, has acquired EuroAPI UK Ltd., a commercial spray drying…
Read More
Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio
BroadOak Capital Partners is pleased to share that Halo Labs has been acquired by Waters Corporation. BroadOak has supported Halo Labs for…
Read More
Rubicon Founders Invests in Horizon Infusions
BroadOak Capital Partners is pleased to share that Rubicon Founders has invested in Horizon Infusions. BroadOak has supported Horizon Infusions for several…
Read More
Werfen acquires Omixon
BroadOak Capital Partners advised Omixon on its sale of the company to Werfen. Omixon, a privately held company based in Budapest, Hungary,…
Read More
PAK BioSolutions Raises $12 Million Series A to Expand Continuous Biomanufacturing Product Line
BroadOak Capital Partners invested in PAK Biosolutions to expand their commercial and product development. The full press release is below. Vienna, VA:…
Read More
LabConnect Acquires A4P Bio
BroadOak Capital Partners advised LabConnect on its acquisition of A4P Bio. A4P Bio provides bioanalytical project management solutions and consultancy for clinical…
Read More
ZoBio Sells to Oncodesign Services
BroadOak Capital Partners advised ZoBio on the sale of the company to Oncodesign Services. ZoBio is a leading provider of biophysics-based small…
Read More
Pluristyx Closes Major Fundraising Round
BroadOak Capital Partners led Pluristyx's latest fundraising round, which featured participation from existing investors and key opinion leaders in the life sciences…
Read More
celares GmbH Sells to Biosynth
BroadOak Capital Partners advised Biosynth on the acquisition of celares GmbH. Celares provides customized bioconjugation solutions for Pharma and IVD industries. The…
Read More
Genomenon Acquires Boston Genetics
Genomenon, a BroadOak portfolio company and a leader in genomic intelligence, acquired Boston Genetics, a genomics interpretation and curation company. The full…
Read More
Indee Labs Investment from BroadOak BioTools Venture Fund
BroadOak Capital Partners invested in Indee Labs out of its BioTools Venture Fund to support the development of Hydropore, which enables modified…
Read More
BroadOak Invests in CDI Laboratories
BroadOak invested in CDI Labs, a provider of serological biomarker discovery services and monoclonal antibody manufacturing and validation services, to expand and…
Read More
PBS Biotech Raises $22M
BroadOak portfolio company PBS Biotech, an innovative manufacturer of single-use bioreactors, has completed a $22 million financing that will be used to…
Read More
Sanguine Biosciences Partners with BroadOak
Sanguine is a leader in custom specimen procurement used by biopharmaceutical companies to accelerate precision medicine and cell & gene therapy R&D.…
Read More
FujiFilm Invests in PhenoVista Biosciences
BroadOak portfolio company PhenoVista Biosciences, a leading provider of both custom and off-the-shelf imaging-based assay services, received an investment from Fujifilm's Life…
Read More
BioCare Medical Acquires Empire Genomics
BioCare Medical, a leading provider of innovative, automated immunohistochemistry (IHC) and FISH (Fluorescent in situ hybridization) instrumentation and reagents, acquired BroadOak portfolio…
Read More
BroadOak Partners with United Biochannels to Acquire ORFLO Technologies
BroadOak partnered with United BioChannels (UBC) to acquire ORFLO Technologies (ORFLO) in October 2022. ORFLO, a leading manufacturer of cell counting and…
Read More
BroadOak Launches BioTools Venture Fund in Collaboration with DeciBio
BroadOak Capital Partners launched the BroadOak BioTools Venture Fund in October 2022 in collaboration with DeciBio, a strategy consulting and market intelligence…
Read More
Flagship Biosciences hires Tom Turi, Ph.D. as CSO
Flagship Biosciences hired industry veteran Tom Turi as Chief Scientific Officer. Tom will help grow the company's spatial biology and biomarker analytics…
Read More
BroadOak Invests in EmVenio Research
BroadOak completed a growth equity investment in EmVenio Research, alongside members of the company's management team in September 2022. EmVenio Research is…
Read More
Flagship Acquires Interpace's Pharma Services Business
Following BroadOak's growth equity investment in Flagship Biosciences, Flagship Biosciences has acquired Interpace Pharma Solutions, a provider of cytogenetic, molecular pathology, and…
Read More
BroadOak Increases Investment in Halo Labs
BroadOak joined Agilent Technologies, a global leader in life sciences and diagnostics, to increase its investment in Halo Labs as part of…
Read More
BroadOak Invests in Microsize
BroadOak invested in Microsize, a CDMO specializing in micronization and particle size control, as part of its launch as an independent business.…
Read More
BroadOak Invests in Kemp Proteins
BroadOak invested in Kemp Proteins, a leading CDMO specializing in the production of novel proteins. The investment will be used to expand…
Read More
BRT Sells to Medix Biochemica
BroadOak Capital Partners advised Bioresource Technology ("BRT") on the sale of the company to Medix Biochemica. BRT is a leading provider of…
Read More
BroadOak Announces Investment in LabVoice
BroadOak invested in LabVoice, a company that leverages device, software, and customized workflows to enable the automated lab. Led by entrepreneurs Frederic…
Read More
Biosynth Carbosynth Acquires Aalto Bio Reagents
BroadOak Partners advised Aalto Bio Reagents on the sale of the company to Biosynth Carbosynth, a KKR and Ampersand portfolio company. The…
Read More
BroadOak Q1 2022 M&A Newsletter
BroadOak's Q1 Quarterly Review analyzes market trends and M&A transactions across life science tools, diagnostics, and services sectors. Read our full Quarterly…
Read More
Biolog Announces New Leadership Team and Investment
BroadOak is pleased to announce its investment in Biolog, a leading provider of cell-based microbial identification and phenotypic profiling technologies. Operating Partner…
Read More
Reaction Biology Acquired by Cobepa
BroadOak portfolio company Reaction Biology Corporation was acquired by Cobepa. Reaction Biology is a leading contract research organization (CRO) that provides drug…
Read More
Genomenon Raises $20M Series B Financing
BroadOak increased its investment in Genomenon, a company that organizes the world's genomic data. The full press release is below. Genomenon Raises…
Read More
BroadOak Q4 2021 M&A Newsletter
BroadOak's Q4 Quarterly Review analyzes market trends and M&A deals across life sciences tools, diagnostics, and services sectors. Read our full Quarterly…
Read More
Rockland Acquires Antibodies-Online
Rockland Immunochemicals, Inc. acquired antibodies-online in a transaction financed by BroadOak Capital Partners. Bill Snider, Partner at BroadOak Capital Partners commented: "We…
Read More
KCAS Acquires FlowMetric
BroadOak Partners advised KCAS, a Vitruvian Partners portfolio company, on the acquisition of FlowMetric, LLC. FlowMetric is a leading provider of flow…
Read More
MyChem Sells To Maravai LifeSciences
BroadOak Partners advises MyChem, LLC on the sale of the company to Maravai LIfeSciences (NASDAQ: MRVI). MyChem is a leading provider of…
Read More
JMI Announces Sale to Element Materials Technology
BroadOak Capital Partners advised JMI Laboratories ("JMI") on the sale of the company to Element Materials Technology ("Element"). JMI is a leading…
Read More
BroadOak Provides $8M Loan to Interpace Biosciences
BroadOak Capital Partners provided a senior term loan to refinance debt held by Interpace's private equity stockholders, Ampersand Capital and 1315 Capital.…
Read More
Nanosyn Sells to Element Materials Technology
BroadOak Partners advises Nanosyn on the sale of the company to Element Materials Technology ("Element"). Nanoysn is a full-service drug discovery CDMO…
Read More
BroadOak Leads Acquisition of Particle Dynamics
An investor group led by BroadOak Capital Partners acquired Particle Dynamics from Edgewater Capital Partners. Particle Dynamics is a global leader in…
Read More
PBS Biotech Raises $10M in Growth Capital
Single-use bioreactor manufacturer, PBS Biotech, recently closed a private $10M funding round with BroadOak Capital Partners. The financing will enable the company…
Read More
Vigene Biosciences Acquired by Charles River Laboratories
BroadOak portfolio company Vigene Biosciences was acquired by Charles River Laboratories. Vigene Biosciences is a leading CDMO providing viral vector manufacturing services…
Read More
Kromatid Receives $2M Investment From BroadOak Capital Partners
BroadOak Capital Partners invested growth capital in KromaTiD. KromaTiD sells structural genomic products and tech-enabled services to optimize gene editing for research…
Read More
KCAS Sells To Vitruvian
BroadOak Capital Partners advised KCAS Bioanalytical and Biomarker Services ("KCAS") on the sale of the company to Vitruvian. KCAS is a leading…
Read More
BroadOak Leads Investment In Genomenon
Genomenon announced that it has completed a $5.3M financing round in the company. The financing will enable the company to expand its…
Read More
Distributed Bio Acquired By Charles River Laboratories
BroadOak portfolio company Distributed Bio was acquired by Charles River Laboratories. Distributed Bio is a provider of innovative antibody discovery, engineering, informatics…
Read More
Bryan Poltilove Joins BroadOak Capital Partners Team
BroadOak Capital Partners is pleased to announce the addition of Bryan Poltilove to its growth capital investing team, where he serves as…
Read More
InFuse Holdings Closes Series A Financing And Acquires Horizon Infusions
BroadOak leads the formation and funding of a new ambulatory infusion platform, InFuse Holdings, to build a network of infusion centers throughout…
Read More
Akron Biotech Acquired By Arcline Investment Management
BroadOak portfolio company Akron Biotech was acquired by Arcline Investment Management. Akron is a provider of GMP-compliant cell-/gene-therapy and engineered tissue products…
Read More
Cenetron Sells To Versiti
BroadOak Partners advised Cenetron Diagnostics ("Cenetron") on the sale of the company to Versiti. Cenetron provides central laboratory services to support global…
Read More
Astero Bio Sells To BioLife Solutions
BroadOak Capital Partners advised Astero Bio Corporation ("Astero") on the sale of the company to BioLife Solutions. Astero is a provider of…
Read More
Reaction Biology Acquires ProQinase GmbH
Reaction Biology Corporation ("RBC"), a BroadOak portfolio company, completes a stock swap transaction whereby RBC acquires all the shares of ProQinase GmbH,…
Read More
BioInformatics Acquires Kalorama Information
BioInformatics, a BroadOak portfolio company, acquires Kalorama Information, a leading market research publisher focused on the in vitro diagnostics, biotechnology, healthcare, medical…
Read More
DANI Instruments Sells To PerkinElmer
BroadOak Partners advises DANI Instruments ("DANI") on its sale to PerkinElmer. DANI is a provider of advanced gas chromatography instruments and systems…
Read More
Distributed Bio Partners With Charles River Laboratories
Distributed Bio, a BroadOak portfolio company, provided Charles River Laboratories' clients access to Distributed Bio's antibody libraries and integrated antibody optimization technologies.…
Read More
LifeSpan Biosciences Sells To Thompson Street
BroadOak Partners advises LifeSpan Biosciences ("LSBio") on the sale of the company to Thompson Street Capital Partners. LSBio provides antibodies and life…
Read More
Astero Bio Acquires Key Assets From MedCision
BroadOak-backed Astero Bio, a leading developer of biologics cryopreservation solutions, acquires key assets and rights related to MedCision, LLC's ThawSTAR cell thawing…
Read More
BioInformatics Acquires IMV Publishing
BioInformatics, a BroadOak portfolio company, acquired IMV Publishing, a leading market research and online publishing business focused on the medical imaging and…
Read More
Lucigen Sells To LGC
BroadOak Partners advises Lucigen Corporation on the sale of the company to LGC Limited. Lucigen is a leading provider of molecular biology…
Read More